Cadila expands oncology portfolio with Bevasizumab biosimilar cancer drug Bevaro™ used in the treatment of multiple cancers . Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of Bevasizumab biosimilar for
Read More
Click Here
